Showing results (361-370 of 486) with videos related to

Sort By:
Pageof 49
International Health|January 29, 2011
The role of mathematical modelling in guiding the science and economics of malaria eliminationRichard J Maude, Yoel Lubell, Duong Socheat, et al.
Journal of Biochemical and Molecular Toxicology|November 18, 2024
Targeting CD36 With EP 80317 Reduces Remote Inflammatory Response to Hind Limb Ischemia-Reperfusion in MiceHanan Elimam, Jade Gauvin, David N Huynh, et al.
PLOS Global Public Health|August 21, 2023
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid testArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
Plos One|March 31, 2016
Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical SettingsYoel Lubell, Thomas Althaus, Stuart D Blacksell, et al.
Public Health Reports (Washington, D.C. : 1974)|April 4, 2020
A Public Health Systems View of Risk Communication About ZikaTara Kirk Sell, Sanjana J Ravi, Crystal Watson, et al.
Cells|March 12, 2025
Selective Azapeptide CD36 Ligand MPE-298 Regulates oxLDL-LOX-1-Mediated Inflammation and Mitochondrial Oxidative Stress in MacrophagesMukandila Mulumba, Catherine Le, Emmanuelle Schelsohn, et al.
Pediatric Emergency Care|June 29, 2023
Development of a Model to Identify Febrile Children at Low Risk for Multisystem Inflammatory SyndromeTamar R Lubell, Mark Gorelik, Dori Abel, et al.
BMC Infectious Diseases|February 6, 2016
Accuracy of commercially available c-reactive protein rapid tests in the context of undifferentiated fevers in rural LaosKoukeo Phommasone, Thomas Althaus, Phonesavanh Souvanthong, et al.
American Journal of Therapeutics|January 11, 2003
Safety of therapeutic beta-blockade in patients with coexisting bronchospastic airway disease and coronary artery diseaseSandeep Khosla, Binu Kunjummen, Rizwan Khaleel, et al.
Journal of Medicinal Chemistry|July 22, 2011
Targeting the prostaglandin F2α receptor for preventing preterm labor with azapeptide tocolyticsCarine B Bourguet, Eugénie Goupil, Danaë Tassy, et al.
Pageof 49